[EN] IMIDAZOTHIADIAZOLE DERIVATIVES AS PROTEASE ACTIVATED RECEPTOR 4 (PAR4) INHIBITORS FOR TREATING PLATELET AGGREGATION<br/>[FR] DÉRIVÉS D'IMIDAZOTHIADIAZOLE UTILISÉS EN TANT QU'INHIBITEURS DES RÉCEPTEURS ACTIVÉS PAR LA PROTÉASE 4 (PAR4) POUR TRAITER L'AGRÉGATION PLAQUETTAIRE
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2013163244A1
公开(公告)日:2013-10-31
The present invention provides imidazothiadiazole compounds of Formula (I) wherein A, B, D, Rx, R1, R2, R3, X1, X2 and s are as defined herein, or a stereoisomer, tautomer, pharmaceutically acceptable salt or solvate form thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of platelet aggregation and thus can be used as medicaments.